In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
2 days 4 hours ago
10 weeks 2 days ago
14 weeks 2 days ago
15 weeks 3 days ago
15 weeks 3 days ago
36 weeks 3 days ago
40 weeks 4 days ago
42 weeks 1 day ago
42 weeks 2 days ago
1 year 2 weeks ago